Phoenix Biotech Acquisition Corp. (PBAX)
Phoenix Biotech Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in Oakland, CA, US. The stock last traded at $5.85, up 6.75% on the session, giving a market capitalisation of $36.5M. On trailing twelve-month figures it carries a trailing P/E of -0.07, a net margin of 0.0%. Its beta of 0.04 implies it has historically moved less than the broad market.
Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.
Phoenix Biotech Acquisition Corp. is most often compared with the following Financial Services names: